Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

EYEGW - Eyegate Pharmaceuticals Inc Warrants 2015-2020 On Shs

Previous close
0.0252
0   0%

Share volume: 0
Last Updated: Wed 05 Aug 2020 06:00:00 AM CEST
Pharmaceuticals: Other: 0%

PREVIOUS CLOSE
CHG
CHG%
$0.03
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
62%
Profitability 75%
Dept financing 25%
Liquidity 18%
Performance 70%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$0.03
P/E Ratio 
N/A
DAY RANGE
$0.03 - $0.03
EPS 
$0.00
52 WEEK RANGE
$0.01 - $0.15
52 WEEK CHANGE
-$55.56
MARKET CAP 
60.148 K
YIELD 
N/A
SHARES OUTSTANDING 
4.627 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$5,708
AVERAGE 30 VOLUME 
$5,990
Company detail
CEO: Stephen From
Region: US
Website: http://www.eyegatepharma.com
Employees: 0
IPO year: -
Issue type:
Market: NASDAQ
Industry: Pharmaceuticals: Other
Sector: Health Technology

EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes EGP-437 and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.

Recent news